Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis
H Yamamoto, J W Soh, T Monden, et al.
Infection and Immunity
|
August 19, 2000
Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)
H Shirin, E M Sordillo, T K Kolevska, et al.
Clinical and Experimental Immunology
|
April 8, 2015
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial
E Israeli, E Goldin, S Fishman, et al.
The American Journal of Gastroenterology
|
December 17, 1997
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial
R Oren, M Moshkowitz, S Odes, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis
H Yamamoto, J W Soh, T Monden, et al.
Infection and Immunity
|
August 19, 2000
Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)
H Shirin, E M Sordillo, T K Kolevska, et al.
Clinical and Experimental Immunology
|
April 8, 2015
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial
E Israeli, E Goldin, S Fishman, et al.
The American Journal of Gastroenterology
|
December 17, 1997
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial
R Oren, M Moshkowitz, S Odes, et al.
Page
of 5